← Leaderboards
Justin P. Kline
University Of Chicago
$3,560,218
Attributed
$3,778,796
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $606.3K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,778,796 · 4
By mechanism
R01$2,692,425 · 2
K23$649,215 · 1
R21$437,156 · 1
Top collaborators
- Jun Huang2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Thomas F Gajewski$23,743,716
- Michael I Nishimura$19,220,002
- Minoli A Perera$7,566,589
- Hans Schreiber$12,391,832
- David O Meltzer$45,291,714
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCancer CellImmunePre-ClinicalT-LymphocyteAntigensEngineeringMalignant NeoplasmsResponseLaboratoriesImmunotherapeutic AgentFuturePreventImmune SystemCellsPrincipal InvestigatorS LymphomaMalignant - DescriptorClinical TrialsEnvironmentLeadBlood SpecimenImmunotherapyMediating
Grant awards (15)
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma$367,186
R01 · FY2025 · CA · contact PI
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma$348,827
R01 · FY2024 · CA · contact PI
Development of antigen multimers for CAR T cell detection and functional profiling$198,078
R21 · FY2024 · AI
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma$367,186
R01 · FY2023 · CA · contact PI
Development of antigen multimers for CAR T cell detection and functional profiling$239,078
R21 · FY2023 · AI
Characterization of a T cell dysfunctional state induced in mice with AML$327,850
R01 · FY2016 · CA · contact PI
Characterization of a T cell dysfunctional state induced in mice with AML$327,850
R01 · FY2015 · CA · contact PI
Characterization of a T cell dysfunctional state induced in mice with AML$318,015
R01 · FY2014 · CA · contact PI
Characterization of a T cell dysfunctional state induced in mice with AML$308,179
R01 · FY2013 · CA · contact PI
Characterization of a T cell dysfunctional state induced in mice with AML$327,332
R01 · FY2012 · CA · contact PI
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy$129,843
K23 · FY2012 · CA · contact PI
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy$129,843
K23 · FY2011 · CA · contact PI
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy$129,843
K23 · FY2010 · CA · contact PI
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy$129,843
K23 · FY2009 · CA · contact PI
Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy$129,843
K23 · FY2008 · CA · contact PI